業績

第37回北海道骨粗鬆症研究会学術集会  トラベリングアワード       大江悠希

Yuka Suzuki MD, Aika Miya MD, PhD, Akinobu Nakamura MD, PhD, Takahisa Handa MD, PhD, Hiraku Kameda MD, PhD, Tatsuya Atsumi MD, PhD

 Perception of hyper-/hypoglycemia and its related factors in type 2 diabetes: A continuous glucose monitoring based prospective observational study. Diabetology International, in press IF 1.3

Fukae J, Amasaki Y, Fujieda Y, Sone Y, Katagishi K, Horie T, Kamishima T, and Atsumi T      Fukae J, Amasaki Y, Fujieda Y, Sone Y, Katagishi K, Horie T, Kamishima T, and Atsumi T       Journal of International Medical Research　in press         IF1.4

Daigo Nakazawa, Sakiko Masuda, Yuka Nishibata, Kanako Watanabe-Kusunoki, Utano Tomaru, Akihiro Ishizu    Neutrophils and NETs in kidney disease    Nature review nephrology, in press       IF 40.0

Kazuro Kamada, Michihito Kono, Tatsuya Atsumi  

Subacute finger gangrene with severe Raynaud’s phenomenon      Intern Med, in press            IF 1

Kazuro Kamada, Yuichiro Fujieda, Mika Watanabe, Tatsuya Atsumi  Skin Eruption and Nerve Impairment: Eosinophil Activation Link           J Rheumatol, in press       IF 3.6

Kitsunai H, Shinozaki Y, Furusawa S, Kitao N, Ito M, Kurihara H, Oba-Yamamoto C, Takeuchi J, Nakamura A, Takiyama Y, Nomoto H.         

The Effect of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: Post-Hoc Analysis of the Sapporo-Oral SEMA Study      Pharmaceuticals, in press　

IF: 4.3

Yuka Suzuki MD, Aika Miya MD, PhD, Akinobu Nakamura MD, PhD, Takahisa Handa MD, PhD, Hiraku Kameda MD, PhD, Tatsuya Atsumi MD, PhD Perception of hyper-/hypoglycemia and its related factors in type 2

diabetes: A continuous glucose monitoring based prospective observational study Diabetology International, in press IF 1.3

Takahashi A, Nomoto H*, Yokoyama H, Yokozeki K, Furusawa S, Oe Y, Kameda R, Kawata S, Miyoshi A, Nagai S, Miya A, Kameda H, Nakamura A, Atsumi T.

Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).

Diabetes Obes Metab, in press

IF 5.4

Moriya H, Fujieda Y, Inoue Y, Miyamoto K, Anada M, Tanaka D, Kudo A, Abe M, Nagai A, Hisada R, Kono M, Kato M, Amengual O, Matsuno Y, Yabe I, Atsumi T Muscle vasculitis in patients with polymyalgia rheumatica; three case series Modern Rheumatology Case Reports

IF: 0.97